Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly
European Journal of Endocrinology · 30.04.2026 · 194 (5) · 732-743
DOI: 10.1093/ejendo/lvag083 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 12.05.2026. Verfasst von Kristin Godang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, 0372 Oslo, Norway. Hauptthemen laut MEDLINE: Acromegaly, Proteomics, Inflammation. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norwegian Institute of Biomedical Science, Fondsstiftelsen, Oslo University Hospital.
Abstract (Originalsprache)
Objective
Biochemical diagnostic approach for acromegaly relies heavily on the 2 biomarkers, growth hormone (GH) and insulin like growth factor 1 (IGF1), known to be dynamically affected, and influencing diagnostic accuracy. We sought to identify disease-specific biomarkers to improve diagnostic and disease activity monitoring and add insight into systemic effects of chronic GH/IGF1 excess.
Methods
Thirty-seven patients diagnosed with acromegaly were enrolled. A sub-cohort (n = 14) of these received primary somatostatin receptor ligand (SRL) treatment before surgery. Plasma samples collected at baseline, preoperative medical treatment and postoperative visits, were used to perform proteomic analysis of 184 proteins, with Olink Target 96 Cardiovascular III and Inflammation panels. Eight proteins were validated Enzyme Immunoassay (EIA). Dual-energy X-ray absorptiometry and biochemical measurements were performed at all visits.
Results
A total of 37 proteins were significantly differentially expressed (P-adjusted < .05) before and after disease control by surgery. Several proteins correlated with GH and IGF1. Interestingly, a strong correlation between some proteins and lean body mass, but not total adipose tissue, was observed. Strong correlation was observed between Olink and EIA measured protein levels. Enrichment analyses revealed 5 clusters, with extracellular matrix (ECM) remodeling and inflammation being most prominent. In addition, 5 proteins showed a temporal change with SRL treatment.
Conclusions
Acromegaly is associated with changes in ECM remodeling and inflammation. Several proteins were linked to disease activity, with glial cell derived neurotrophic factor and insulin like growth factor binding protein 2 serving as promising plasma biomarkers with potential to further optimize management of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, 0372 Oslo, Norway.
- Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.
- Research Institute of Internal Medicine, Oslo University Hospital, 0372 Oslo, Norway.
- Department of Cardiothoracic and Vascular Surgery, University Hospital of North Norway, 9019 Tromsø, Norway.
- Department of Medical Biochemistry, Oslo University Hospital, 0450 Oslo, Norway.
ORCID-Profile: Maren Ileby Wessel, Thor Ueland, Jens Bollerslev, Nicoleta Cristina Olarescu
Förderung
- Norwegian Institute of Biomedical Science
- Fondsstiftelsen
- Oslo University Hospital
Zitieren
APA
Godang, K., Wessel, M. I., Khan, Y., Ueland, T., Lekva, T., Berg, J. P., Bollerslev, J., & Olarescu, N. C. (2026). Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly. European Journal of Endocrinology, 194(5), 732-743. https://doi.org/10.1093/ejendo/lvag083
Vancouver
Godang K, Wessel MI, Khan Y, Ueland T, Lekva T, Berg JP, et al. Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly. European Journal of Endocrinology. 2026;194(5):732-743. doi:10.1093/ejendo/lvag083
BibTeX
@article{Godang2026,
author = {Godang, Kristin and Wessel, Maren Ileby and Khan, Yusuf and Ueland, Thor and Lekva, Tove and Berg, Jens Petter and Bollerslev, Jens and Olarescu, Nicoleta Cristina},
title = {Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly},
journal = {European Journal of Endocrinology},
year = {2026},
volume = {194},
number = {5},
pages = {732--743},
doi = {10.1093/ejendo/lvag083}
}
EUVIMED